PP
ANIP icon

Paloma Partners’s ANI Pharmaceuticals ANIP Stock Holding History

Paloma Partners’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-4,473
Closed -$276K – 1225
2019
Q4 		$276K Buy
4,473
+1,268
+40% +$84K 0.01% 1800
2019
Q3 		$234K Buy
+3,205
New +$240K 0.01% 1673
2019
Q2 		– Sell
-4,164
Closed -$294K – 1705
2019
Q1 		$294K Buy
+4,164
New +$245K 0.01% 1324
2018
Q4 		– Sell
-4,224
Closed -$239K – 1251
2018
Q3 		$239K Buy
+4,224
New +$258K 0.01% 1321
2017
Q2 		– Sell
-29,783
Closed -$1.48M – 2141
2017
Q1 		$1.48M Buy
29,783
+10,351
+53% +$581K 0.04% 993
2016
Q4 		$1.18M Buy
+19,432
New +$1.19M 0.03% 1071

Other funds holding ANIP

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ICOM
Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return